🩹Recovery & Healing

A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.

A synthetic version of the naturally occurring 43-amino acid peptide Thymosin Beta-4, widely used for tissue repair, wound healing, reduced inflammation, and improved flexibility.

The arginine salt form of BPC-157, optimized for oral bioavailability and stability, used interchangeably with BPC-157 for tissue healing and gut repair.

A porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids, used clinically in many countries for stroke recovery, traumatic brain injury, and dementia.

A naturally occurring copper-binding tripeptide that declines with age, known for potent wound healing, collagen stimulation, anti-aging skin effects, and hair growth promotion.

A synthetic hexapeptide growth hormone secretagogue that potently stimulates GH release through the ghrelin receptor, with additional cardioprotective properties.

The only human cathelicidin antimicrobial peptide, a 37-amino acid peptide beginning with two leucines, with broad-spectrum antimicrobial, anti-biofilm, immunomodulatory, and wound healing properties.

A mitochondria-targeted tetrapeptide that concentrates in the inner mitochondrial membrane, protecting cardiolipin and restoring bioenergetics in aging and disease.

A semi-synthetic polysaccharide (heparin-like compound) used clinically for interstitial cystitis and osteoarthritis, with disease-modifying effects on cartilage, joints, and the glycosaminoglycan layer.

A long-acting growth hormone-releasing hormone (GHRH) analog with a Drug Affinity Complex that extends its half-life to 6-8 days, producing sustained elevated growth hormone and IGF-1 levels.

A synthetic hexapeptide growth hormone secretagogue that stimulates GH release through the ghrelin receptor (GHS-R1a), notable for its potent GH-releasing effects and strong appetite stimulation.

A naturally occurring anti-inflammatory tripeptide derived from the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH), studied for its potent anti-inflammatory effects in the gut, skin, and systemically.

A highly selective growth hormone-releasing peptide (GHRP) that stimulates GH release with minimal impact on cortisol, prolactin, or appetite, making it the cleanest GHRP available.

An orally active, non-peptide growth hormone secretagogue that mimics ghrelin to raise GH and IGF-1 levels for up to 24 hours per dose, with notable effects on sleep, appetite, and body composition.

A modified growth hormone-releasing hormone fragment with a short half-life (~30 minutes) that stimulates pulsatile growth hormone release, closely mimicking the body's natural GH secretion pattern.

The first 29 amino acids of natural GHRH, previously FDA-approved for pediatric GH deficiency. Now widely used off-label for anti-aging GH optimization as a safer alternative to direct HGH therapy.

A synthetic hexapeptide growth hormone secretagogue considered to offer the best balance of potency and side effect profile among the GHRP family.

A mitochondria-derived peptide that acts as an exercise mimetic, improving metabolic health, insulin sensitivity, and physical performance through AMPK activation.

A mitochondria-derived 24-amino acid peptide with potent cytoprotective and neuroprotective effects, being studied for Alzheimer's disease, metabolic health, and longevity.

A 28-amino acid thymic peptide that modulates immune function, approved in multiple countries for hepatitis B and used as an immune enhancer in cancer and infectious disease.

A modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits lipogenesis without the diabetogenic or growth-promoting effects of full-length HGH.

An oligopeptide derived from angiotensin IV that is reported to be 10 million times more potent than BDNF at enhancing cognitive function through hepatocyte growth factor (HGF) signaling.

A D-retro-inverso peptide that selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction, representing a targeted senolytic approach to aging.

A naturally occurring nonapeptide that promotes delta-wave deep sleep, modulates stress hormones, and has potential applications in insomnia, pain, and withdrawal syndromes.

A 28-amino acid neuropeptide with broad immunomodulatory, vasodilatory, and anti-inflammatory effects, used in CIRS (Chronic Inflammatory Response Syndrome) protocols and researched for pulmonary conditions.

A synthetic octapeptide that regulates intestinal tight junctions, developed as the first drug to target intestinal permeability ('leaky gut') in celiac disease and other conditions.

A thymic peptide bioregulator developed in Russia that restores immune function by promoting T-cell maturation and has shown anti-aging effects in clinical studies on elderly patients.

A cell-penetrating peptide that activates the Wnt/β-catenin signaling pathway to stimulate hair follicle neogenesis and promote hair growth, representing a novel approach to treating hair loss.

A small synthetic peptide derived from ciliary neurotrophic factor (CNTF) that promotes neurogenesis and enhances cognitive function by inhibiting leukemia inhibitory factor (LIF) signaling.

A zinc-dependent nonapeptide hormone produced by thymic epithelial cells that plays an essential role in T-cell differentiation and immune regulation, declining significantly with age.